Cargando…
Signaling pathways that regulate adaptive β‐cell proliferation for the treatment of diabetes
The decline in β‐cell mass due to the failure of β‐cell compensation is one cause of the development of type 2 diabetes. Therefore, elucidation of the mechanism by which an adaptive increase in β‐cell mass occurs in vivo will lead to the development of a cure for diabetes. Insulin and insulin recept...
Autor principal: | Shirakawa, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204178/ https://www.ncbi.nlm.nih.gov/pubmed/36871280 http://dx.doi.org/10.1111/jdi.14002 |
Ejemplares similares
-
Revisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes
por: Sasaki, Hironobu, et al.
Publicado: (2021) -
Inside the β Cell: Molecular Stress Response Pathways in Diabetes Pathogenesis
por: Kulkarni, Abhishek, et al.
Publicado: (2022) -
Nfat: ubiquitous regulator of cell differentiation and adaptation
por: Horsley, Valerie, et al.
Publicado: (2002) -
β cell replacement therapy for the cure of diabetes
por: Lee, Joonyub, et al.
Publicado: (2022) -
Cellular signaling pathways regulating β-cell proliferation as a promising therapeutic target in the treatment of diabetes
por: Jiang, Wen-Juan, et al.
Publicado: (2018)